First Time Loading...

Alkermes Plc
NASDAQ:ALKS

Watchlist Manager
Alkermes Plc Logo
Alkermes Plc
NASDAQ:ALKS
Watchlist
Price: 23.86 USD -0.62% Market Closed
Updated: May 3, 2024

Alkermes Plc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alkermes Plc
Operating Income Peer Comparison

Comparables:
AMRN
PRTA
M
MURA

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Alkermes Plc
NASDAQ:ALKS
Operating Income
$420.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
28%
Amarin Corporation PLC
NASDAQ:AMRN
Operating Income
-$17.4m
CAGR 3-Years
4%
CAGR 5-Years
31%
CAGR 10-Years
21%
Prothena Corporation PLC
NASDAQ:PRTA
Operating Income
-$191m
CAGR 3-Years
-19%
CAGR 5-Years
-6%
CAGR 10-Years
-17%
M
Mural Oncology PLC
NASDAQ:MURA
Operating Income
-$196.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Alkermes Plc's Operating Income?
Operating Income
420.1m USD

Based on the financial report for Dec 31, 2023, Alkermes Plc's Operating Income amounts to 420.1m USD.

What is Alkermes Plc's Operating Income growth rate?
Operating Income CAGR 10Y
28%